Contact Us

Baycol
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

What additional medications were you taking at the time?

Was Gemfibrozil (Lopid) taken while taking Baycol?

Has Rhabdomyolysis been diagnosed?

Have any of the following side effects occurred?







Please further describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Bayer May Settle Some Baycol Claims

Aug 7, 2002 | AP

Bayer AG may be prepared to settle some claims over an anti-cholesterol drug withdrawn after it was linked to patient deaths, but the company sees no grounds for a full-scale settlement, the chief executive was quoted as saying Wednesday.

In a preview of an interview with the WirtschaftsWoche weekly, Werner Wenning also said Bayer could cut another 4,000 jobs as it combines its farm chemicals business with its $7 billion acquisition, Aventis CropScience, that was completed in June.

Beyond that, "there may be further job cuts due to restructuring," Wenning told the weekly.

The decision adds to 6,300 job cuts already announced to the 128,000 Bayer employees. The company had planned to drop 5,000 jobs by 2005 under cuts decided before its key Baycol drug was withdrawn, and it has announced 1,300 more since.

Bayer, based in Leverkusen, is in the midst of an overhaul launched last year after links to more than 50 patient deaths forced it to pull Baycol, marketed as Lipobay in some countries.

Bayer was hit by lawsuits seeking damages for patients and their relatives over the recalled drug. It insisted the claims are groundless and says it has set no money aside for possible compensation payments.

In the interview, Wenning said the company might consider settling some individual lawsuits brought over the drug, but insisted that Bayer "acted properly on the basis of the contemporary state of knowledge."


Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo